Chiral beta-hydroxyethylamines and their use in the treatment of hyperglycemia
US11793774B2 · kind B2 · utility
0Cited by
31References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 13, 2018 |
| Grant date | Oct 24, 2023 |
| Priority date | — |
| Expiry date | Apr 20, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07B2200/07
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
There is herein provided a compound of formula (I) or a pharmaceutically acceptable salt thereof, wherein X, R1, R2, R3, R4 and n have meanings as provided in the description.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.